ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,261.80
0.50%
S&P ASX All Technology
3,859.50
0.90%
Brent Oil
73.44
0.00%
US Dollar vs AUD
1.61005
0.00%
Bitcoin
94,461.83
0.32%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Dyne Therapeutics Inc (DYN) Share Price

Dyne Therapeutics Inc

Dyne Therapeutics Inc (DYN)

NASDAQ
23.72
-0.75
(-3.06%)
Closed 28 December 8:00AM
Delayed by 15 minutes
23.72
0.01
(0.04%)
After Hours: 9:44AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
23.72
Bid
23.72
Offer
26.61
Volume
683,735
23.40 Day's Range 24.88
12.33 52 Week Range 47.45
Market Cap
2.414B
Previous Close
24.47
Open
24.20
Last Trade
437
@
23.72
(formt)
Last Trade Time
Financial Volume
US$ 16,413,783
VWAP
24.0061
Average Volume (3m)
900,388
Shares Outstanding
101,765,958
Dividend Yield
-
PE Ratio
-10.23
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-235.94M

About Dyne Therapeutics Inc

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.dyne-tx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was US$24.47. Over the last year, Dyne Therapeutics shares have traded in a share price range of US$ 12.33 to US$ 47.45.

Dyne Therapeutics currently has 101,765,958 shares in issue. The market capitalisation of Dyne Therapeutics is US$2.49 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -10.23.

Ask ADVFN Intelligence (AI)

DYN Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

12 December 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

12 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

11 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 December 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 December 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

26 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

23 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

19 November 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.11-0.46160302140223.8324.923.3164488724.0370519CS
4-7.125-23.099367806830.84531.2923.3174994926.65979246CS
12-10.28-30.23529411763435.923.3190038829.75284201CS
26-10.28-30.23529411763447.4523.31111351434.8082287CS
5210.9585.747846515312.7747.4512.33140752828.26681025CS
15610.8684.447900466612.8647.454.370615422.38502052CS
2600.271.1513859275123.4547.454.357997821.81484544CS

DYN - Frequently Asked Questions (FAQ)

What is the current Dyne Therapeutics share price?
The current share price of Dyne Therapeutics is US$ 23.72
How many Dyne Therapeutics shares are in issue?
Dyne Therapeutics has 101,765,958 shares in issue
What is the market cap of Dyne Therapeutics?
The market capitalisation of Dyne Therapeutics is USD 2.49B
What is the 1 year trading range for Dyne Therapeutics share price?
Dyne Therapeutics has traded in the range of US$ 12.33 to US$ 47.45 during the past year
What is the PE ratio of Dyne Therapeutics?
The price to earnings ratio of Dyne Therapeutics is -10.23
What is the reporting currency for Dyne Therapeutics?
Dyne Therapeutics reports financial results in USD
What is the latest annual profit for Dyne Therapeutics?
The latest annual profit of Dyne Therapeutics is USD -235.94M
What is the registered address of Dyne Therapeutics?
The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Dyne Therapeutics website address?
The website address for Dyne Therapeutics is www.dyne-tx.com
Which industry sector does Dyne Therapeutics operate in?
Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
US$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.94M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
131.96M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.94M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.78M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
267.99M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

Discussion

View Full Feed
955 955 3 minutes ago
Could it be F&F opponents in DC are taking that position due to the fact the GSE's have been so politicized over the years?
spectrader82 spectrader82 3 minutes ago
So does the CEO not care about the CE or what?

How can there be no communication after so long with a ce keeping stock down 99%?
CCTL
mrfence mrfence 3 minutes ago
The GSE'S should put the UST in Conservatorship.
FNMA
Slightlybetter0 Slightlybetter0 4 minutes ago
https://www.sec.gov/submit-tip-or-complaint

That’s it, that’s the link. I think a letter of any kind to management is a waste of time. They have proven time and time again they do not care about shareholders and their sentiment. If you/we want to pursue a serious escalation the it’s d
MVNT
rx7171 rx7171 4 minutes ago
90 minutes!
They will explain everything down to the bone.
I assume including serious Q&A time.
AVXL
againstallodds againstallodds 5 minutes ago
Just a share selling scam
GNCP
ktcougar ktcougar 9 minutes ago
I have a sign next to my computer that says.....Don't be greedy lol.
I can NOT believe
how expensive the OTM July Calls (ALL strikes) are...😳
The Jan $25's closed at .49 today with 873 traded.....way to expensive for me! After seeing the way that was trading I didn't l
ATOM
John Doe 2024 John Doe 2024 9 minutes ago
So Dave is the clown we all should be blaming for not being able to get Nexboard certified in any way after over 3 years which led them to have to bring in outside help?????
XERI
Fdc4 Fdc4 11 minutes ago
Absolutely no…. Bullocks…. LMAO. These companies go ONLY to FINRA because they are the big dogs that provides the blessing to move forward with their name. If you see any other 3rd party entities showing a diff name, it means nothing. Now, the moment YOU see a broker showing the ticker as $JFHE then
JFHE
Guzzi62 Guzzi62 11 minutes ago
I am surprised you are so helpless and starts screaming like a little baby when you are not getting attention.

Grow up man!
AVXL
skitahoe skitahoe 11 minutes ago
When we gain UK approval, I believe that NWBO will largely make Advent responsible for manufacturing, storage, distribution and supply of the vaccine in the UK. I suspect they'll grow slightly in size at NWBO, but not that much. I believe much the same will be true as the approval of EDEN has NWBO
NWBO
cojoboy cojoboy 12 minutes ago
Good for them..sell and move on to they're next lose.imo
CGAC
Boiler_Master Boiler_Master 12 minutes ago
So hyla. com was already taken and they went with tryhyla. com, who cares? It's just a subsidiary of EDXC. And ask for online sales, are you aware every single state has their own laws and permitting processes for selling age restricted products online? They were up to 9 states, then partnered with
EDXC
cojoboy cojoboy 13 minutes ago
Well.I grabbed what hoped is the bottom @ 4's..saw some 3's posted..that's just mm..b.s.
CGAC
rayovac812 rayovac812 14 minutes ago
Only hope is an after replay?

If there is any new material, they will have to PR the morning of the JPM Conference at the latest. Could be a setup for a release of results we already are expecting, before the conference.
JPM
cableguy cableguy 14 minutes ago
Boy, now why you want to lie?? huh?? 26.3 milly traded today and everyone sold, LoL.. get off your daddies computer and get to bed... problem is your not even good at it, charts don't lie only people do... 2,806,171,707 accumulated


https://investorshub.advfn.com/uimage/uploa
ASII
DrivenByPain DrivenByPain 15 minutes ago
L2 SGDH 12/27/2024

https://investorshub.advfn.com/uimage/uploads/2024/12/27/bijhlL2sSGDH.png insert-text-here
SGDH
Motor-goater Motor-goater 17 minutes ago
Prodigy appears to be up and running but what about dem boyz??
CNNA
gitreal gitreal 18 minutes ago
The serial nature of the scam being run here has been discussed over and over here.....SRGE and CRGP should be familiar names for anybody paying attention. When he says he knows nothing about those stocks.....I don't believe him. Nobody could be that willfully uninformed.
CRGP
tat4tat tat4tat 19 minutes ago
New X post stating $48,000.00 taken in today by 1 pst. Daily $63,000.00. They say they are sprinting to the finish line. Did they forget that the quarter ended on Sept 30th. Someone wake up the accountant. No Q ... numbers stated in X mean nothing.
CEOS
Preciouslife1 Preciouslife1 19 minutes ago
https://www.mlb.com/news/longest-home-run-of-2024-for-every-mlb-team
Fdc4 Fdc4 20 minutes ago
The only website that you will see out there showing any signs that CEO is really trying or securing the company new name and ticker from being taken is the Nevada Gov site and SEC.gov. FINRA does not provide any sign of such in their site until it is done.


Yes: CEO receives p
SMCE
gitreal gitreal 21 minutes ago
IT WAS A JOKE!!!!

Was it? Okay, I'll take your word for it.

But......regardless.......NBRI's CEO is a cheater. Cheated securities rules with his old company and got fined. And now, he's lying about a bunch of stuff....rhodium.....PGM's......gold grades......statu
NBRI

Your Recent History

NASDAQ
DYN
Dyne Therapeutics
BIT
P1U9S0
BNP Paribas Issuance
LSE
0G4V
Suedwestdeutsche Salzwerke
AQSE
VWRL.GB
Vanguard Ftse Allworld U...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads